Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: Toxicity, pharmacokinetics, and biological effects

Joachim Lorenz, Kai Wilhelm, Mathias Kessler, Christian Peschel, Udo Schwulera, Reinhold Lissner, Wilhelm G. Struff, Edith Huland, Christoph Huber, Walter E. Aulitzky

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: Toxicity, pharmacokinetics, and biological effects'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science